id crelsevierbv:10.1016/j.annonc.2020.02.006
record_format openpolar
spelling crelsevierbv:10.1016/j.annonc.2020.02.006 2024-05-19T07:34:39+00:00 ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer Planchard, D. Reinmuth, N. Orlov, S. Fischer, J.R. Sugawara, S. Mandziuk, S. Marquez-Medina, D. Novello, S. Takeda, Y. Soo, R. Park, K. McCleod, M. Geater, S.L. Powell, M. May, R. Scheuring, U. Stockman, P. Kowalski, D. AstraZeneca 2020 http://dx.doi.org/10.1016/j.annonc.2020.02.006 https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/plain en eng Elsevier BV https://www.elsevier.com/tdm/userlicense/1.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ Annals of Oncology volume 31, issue 5, page 609-618 ISSN 0923-7534 journal-article 2020 crelsevierbv https://doi.org/10.1016/j.annonc.2020.02.006 2024-04-24T07:08:00Z Article in Journal/Newspaper Arctic ScienceDirect (Elsevier) Annals of Oncology 31 5 609 618
institution Open Polar
collection ScienceDirect (Elsevier)
op_collection_id crelsevierbv
language English
author2 AstraZeneca
format Article in Journal/Newspaper
author Planchard, D.
Reinmuth, N.
Orlov, S.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Marquez-Medina, D.
Novello, S.
Takeda, Y.
Soo, R.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Scheuring, U.
Stockman, P.
Kowalski, D.
spellingShingle Planchard, D.
Reinmuth, N.
Orlov, S.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Marquez-Medina, D.
Novello, S.
Takeda, Y.
Soo, R.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Scheuring, U.
Stockman, P.
Kowalski, D.
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
author_facet Planchard, D.
Reinmuth, N.
Orlov, S.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Marquez-Medina, D.
Novello, S.
Takeda, Y.
Soo, R.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Scheuring, U.
Stockman, P.
Kowalski, D.
author_sort Planchard, D.
title ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
title_short ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
title_full ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
title_fullStr ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
title_full_unstemmed ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
title_sort arctic: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
publisher Elsevier BV
publishDate 2020
url http://dx.doi.org/10.1016/j.annonc.2020.02.006
https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753420360415?httpAccept=text/plain
genre Arctic
genre_facet Arctic
op_source Annals of Oncology
volume 31, issue 5, page 609-618
ISSN 0923-7534
op_rights https://www.elsevier.com/tdm/userlicense/1.0/
http://creativecommons.org/licenses/by-nc-nd/4.0/
op_doi https://doi.org/10.1016/j.annonc.2020.02.006
container_title Annals of Oncology
container_volume 31
container_issue 5
container_start_page 609
op_container_end_page 618
_version_ 1799472820105773056